Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10208052 Compositions for activating pyruvate kinase

Patent 10208052 was granted and assigned to FORMA Therapeutics on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+232 characters)
Article

Patent abstract

Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
David R. Lancia, Jr.0
Gary Gustafson0
Lorna Mitchell0
Neal Green0
Tatiana Shelekhin0
Xiaozhang Zheng0
Edits on 14 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11673888 Bicyclic compounds as ATX inhibitors
0
Edits on 17 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11649242 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 10669268 Bicyclic derivatives
0
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 22 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
FORMA Therapeutics
FORMA Therapeutics
0
Current Assignee
FORMA Therapeutics
FORMA Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102080520
Date of Patent
February 19, 2019
0
Patent Application Number
159262360
Date Filed
March 20, 2018
0
Patent Citations Received
‌
US Patent 10472371 Compositions for activating pyruvate kinase
0
‌
US Patent 10633384 Diazaspirocycloalkane and azaspirocycloalkane
0
‌
US Patent 10640472 Phenoxymethyl derivatives
0
‌
US Patent 10647719 Bicyclic compounds as dual ATX/CA inhibitors
0
‌
US Patent 10654857 Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
0
‌
US Patent 10669268 Bicyclic derivatives
0
‌
US Patent 10669285 Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
0
‌
US Patent 10675274 Activating pyruvate kinase R
0
‌
US Patent 10676446 Bicyclic quinazolinone derivatives
0
‌
US Patent 10738053 Bicyclic compounds as dual ATX/CA inhibitors
0
‌
US Patent 10787459 Bicyclic compounds as ATX inhibitors
0
‌
US Patent 10800786 Bicyclic compounds as ATX inhibitors
0
‌
US Patent 10836771 Compositions for activating pyruvate kinase
0
‌
US Patent 10849881 Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl
0
‌
US Patent 10882857 Bicyclic compounds as ATX inhibitors
0
‌
US Patent 10889588 Bicyclic compounds as dual ATX/CA inhibitors
0
‌
US Patent 10913745 Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
0
‌
US Patent 11001588 Activating pyruvate kinase R and mutants thereof
0
‌
US Patent 11014927 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
0
‌
US Patent 11059794 Heterocyclic compounds useful as dual ATX/CA inhibitors
0
‌
US Patent 11071725 Activating pyruvate kinase R
0
‌
US Patent 11352330 Phenoxymethyl derivatives
0
‌
US Patent 11396513 Compositions for activating pyruvate kinase
0
Patent Primary Examiner
‌
Brian J Davis
0

Find more entities like US Patent 10208052 Compositions for activating pyruvate kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo